[Meeting report of the 39th Annual Conference of the American Society of Clinical Oncology (ASCO), 5/31-6/3/2003, Chicago, USA].
D006801:Humans; D007167:Immunotherapy; D008197:Lymph Node Excision; D008207:Lymphatic Metastasis; D008495:Medical Oncology; D008545:Melanoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008991:Monitoring, Physiologic; D015337:Multicenter Studies as Topic; D009362:Neoplasm Metastasis; D011379:Prognosis; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D012955:Societies, Medical; D013997:Time Factors; D014481:United States